Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady As Chief Executive Officer To Lead Strategic Growth - NSRX News | RalliesNasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady As Chief Executive Officer To Lead Strategic Growth
N
NSRX• Brendan P. O'Grady named CEO
- Nasus Pharma Ltd. appointed pharmaceutical industry veteran Brendan P. O'Grady as chief executive officer to lead strategic growth.
- O'Grady succeeds Dan Teleman as CEO effective July 27, 2026.
•
